FDA Deputy Commissioner Details Agency’s Priorities In Recent Speech


In This Issue:

- Snapshot of the Agency: FDA-regulated products

- Recent Public Health Milestones

- Innovative Programs at FDA

..A. FDA has a number of programs intended to speed the availability of promising new therapies to patents with serious and life-threatening illnesses.

..B. Pediatric & Rare Disease Initiatives

..C. Drug, Biologics & Device Innovation

..D. Advancements in Clinical Trials

- Cross-FDA Alignment Initiatives

- Policy Initiatives Underway

- Excerpt from Snapshot of the Agency: FDA-regulated products:

Products Regulated by FDA Include:

- Human Drugs

- Rx, OTC, Generics

- Vaccines, Blood Products, and Other Biologics

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Polsinelli | Attorney Advertising

Written by:


Polsinelli on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.